Staidson

Staidson
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.23
Market Cap
CNY5.68 B
Shares Outstanding
466.65 M
Public Float
155.74 M

Profile

Address
36 Jinghai 2nd Road
Beijing Beijing 100176
China
Employees -
Website http://www.staidson.com
Updated 07/08/2019
Staidson (Beijing) Biopharmaceuticals Co., Ltd. engages in the research, development, production, and sale of independent intellectual property innovation drugs. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin. The company was founded on August 16, 2002 and is headquartered in Beijing, China.

Financials

View All

Zhi Wen Zhou
Chairman
Hong Shan Zhang
Chairman-Supervisory Board